Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C
This study has been completed.
Sponsor:
Idenix Pharmaceuticals
Information provided by:
Idenix Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00120835
First received: July 11, 2005
Last updated: June 9, 2010
Last verified: June 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | No date given |